Pure Global

GLENBIO Total Bilirubin Reagent DBD - Indonesia BPOM Medical Device Registration

GLENBIO Total Bilirubin Reagent DBD is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101221436. The device is manufactured by GLENBIO LTD. from United Kingdom, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. ARDIKHA UMRAN ABADI.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
GLENBIO Total Bilirubin Reagent DBD
Analysis ID: AKL 20101221436

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Manufacturer

GLENBIO LTD.

Country of Origin

United Kingdom

Authorized Representative

PT. ARDIKHA UMRAN ABADI

AR Address

Jl. Bintara VIII Nomor 100 A

Registration Date

Sep 06, 2022

Expiry Date

Jan 03, 2027

Product Type

Clinical Chemistry Test System

Bilirubin (total or direct) test system (kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing